OCCL Limited
OCCL Limited (OCCLLTD) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals
occlindia.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 107 Cr | 123 Cr | 120 Cr | 114 Cr |
| Operating expenses (approx.) | 89 Cr | 97 Cr | 100 Cr | 94 Cr |
| EBITDA | 19 Cr | 26 Cr | 19 Cr | 20 Cr |
| OPM % | 17.4% | 21.4% | 16.1% | 17.3% |
| Other income | 0.98 Cr | 0.40 Cr | 0.98 Cr | 0.45 Cr |
| Interest | 1 Cr | 1 Cr | 1 Cr | 1 Cr |
| Depreciation | 7 Cr | 7 Cr | 7 Cr | 7 Cr |
| Profit before tax | 11 Cr | 18 Cr | 12 Cr | 8 Cr |
| Tax % | 23.6% | 28.4% | 24.8% | 23.2% |
| Net profit | 9 Cr | 13 Cr | 9 Cr | 7 Cr |
| EPS (₹) | ₹1.74 | ₹2.63 | ₹1.74 | ₹1.31 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 307 Cr | Sign in for TTM |
| Operating expenses (approx.) | 254 Cr | Sign in for TTM |
| EBITDA | 53 Cr | Sign in for TTM |
| OPM % | 17.3% | Sign in for TTM |
| Other income | 2 Cr | Sign in for TTM |
| Interest | 5 Cr | Sign in for TTM |
| Depreciation | 21 Cr | Sign in for TTM |
| Profit before tax | 29 Cr | Sign in for TTM |
| Tax % | 25.1% | Sign in for TTM |
| Net profit | 21 Cr | Sign in for TTM |
| EPS (₹) | ₹4.29 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 10 Cr |
| Reserves | 386 Cr |
| Borrowings | 56 Cr |
| Other liabilities | 82 Cr |
| Total liabilities | 534 Cr |
| Fixed assets (net) | 378 Cr |
| CWIP | 3 Cr |
| Investments | 11 Cr |
| Loans & advances | 1 Cr |
| Inventories | 60 Cr |
| Trade receivables | 65 Cr |
| Cash & bank | 0.21 Cr |
| Other assets | 16 Cr |
| Total assets | 534 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 70 Cr |
| Cash from investing | -26 Cr |
| Cash from financing | -44 Cr |
| Net cash flow | 0.15 Cr |
| Free cash flow (OCF − Capex) | 57 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 7.5% |
| ROE % | 5.4% |
| Debtor days | 77 |
| Inventory days | 186 |
| Days payable | 73 |
| Cash conversion cycle | 190 |
| Debt / equity | 0.14 |
| Current ratio | 1.87 |
| Net debt / EBITDA | 1.06 |
Compare with peers
Loading peers…